Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Recruiting 11Terminated 6Active not recruiting 6Unknown 4Completed 4Not yet recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3Sarcoma 1

Conditions

Urinary Bladder Neoplasms 3Sarcoma 1Pathologic Complete Response 1Neoplasms 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × Transurethral Resection of Bladder × Clear all
NCT06324058 2024-03-21

Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC

Huashan Hospital

Phase NA Unknown
190 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT05684874 2023-10-30

SarQuantIRM

Centre Leon Berard

Phase NA Unknown
25 enrolled
Sarcoma

Pathologic Complete Response, Neoplasms, Sarcoma

NCT05445648 2022-12-28

CBPTMI

First Affiliated Hospital Xi'an Jiaotong University

Phase 2 Unknown
65 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT05123404 2021-11-17

Validation of VI-RADS for the Detection of Detrusor Muscle Invasion

Egyptian Biomedical Research Network

Phase NA Unknown
60 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡